DUPIXENT
Drug timelines are a Plus or Pro feature.
87 regulatory and trial events tracked for DUPIXENT, covering 2016-08-22 to 2026-08-18. Get the full timeline:
Most recent: EMA Authorised: Dupixent (dupilumab) — Sanofi Winthrop Industrie
87 regulatory and trial events tracked for DUPIXENT, covering 2016-08-22 to 2026-08-18. Get the full timeline:
Most recent: EMA Authorised: Dupixent (dupilumab) — Sanofi Winthrop Industrie